A2A Pharmaceuticals
A2A Pharmaceuticals's Overview
A2A Pharmaceuticals is a biotechnology company at the forefront of innovative drug discovery, utilizing its proprietary artificial intelligence (AI) platform, SCULPT™. This advanced technology facilitates the design and development of novel small molecule therapeutics aimed at challenging disease targets. The company focuses on critical unmet medical needs, particularly in oncology, and other life-threatening conditions. A2A's approach emphasizes speed and precision in identifying promising drug candidates, aiming to accelerate the journey from lab to patient.
Where is A2A Pharmaceuticals's Headquarters?
HQ Function
Serves as the central hub for A2A Pharmaceuticals' research and development operations, strategic planning, and administrative functions, focusing on leveraging its AI platform for drug discovery.
Notable Features:
The headquarters likely houses computational drug design infrastructure and facilitates collaboration among its scientific and management teams. Specific architectural details are not publicly emphasized, typical for a research-focused biotech.
Work Culture:
As a company driven by cutting-edge AI and drug discovery, the work culture at A2A Pharmaceuticals likely fosters innovation, scientific rigor, collaboration, and a fast-paced environment focused on achieving breakthroughs in challenging therapeutic areas.
HQ Significance:
The Nanuet headquarters is significant as the core operational base for A2A's pioneering AI-driven drug discovery efforts, contributing to the biotech ecosystem in the New York area.
Values Reflected in HQ: The headquarters operations reflect A2A's commitment to innovation, scientific excellence, and the pursuit of novel therapies for unmet medical needs through advanced technology.
Location:
While A2A Pharmaceuticals is headquartered in the USA, its impact and collaborations may extend globally. The company's focus on AI-driven drug discovery allows for potential international partnerships with research institutions, pharmaceutical companies, and participation in global clinical trials. Their innovative platform has the potential to address diseases affecting populations worldwide, indicating a global outlook in their mission and research efforts, even if physical office presence is concentrated.
Street Address:
2220 Dapplemere Grove
City:
Nanuet
State/Province:
NY
Country:
USA
A2A Pharmaceuticals's Global Presence
N/A - Focus on Nanuet HQ
Address: N/A
Focus is on leveraging the Nanuet headquarters for primary R&D and corporate functions.
Buying Intent Signals for A2A Pharmaceuticals
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
Executive Team of A2A Pharmaceuticals
As of April 2025, A2A Pharmaceuticals' leadership includes:
Investors of A2A Pharmaceuticals
A2A Pharmaceuticals has been backed by several prominent investors over the years, including:
Executive New Hires/Exits in the Last 12 Months
No major publicly announced executive hires or exits have been identified for A2A Pharmaceuticals in the last 12 months. The company appears to maintain stability in its core leadership team as it advances its drug discovery programs.
Technology (Tech Stack) used by A2A Pharmaceuticals
Discover the tools A2A Pharmaceuticals uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
A2A Pharmaceuticals Email Formats and Examples
A2A Pharmaceuticals likely utilizes common professional email formats for its corporate communications. While specific internal structures can vary, a typical format for companies of its size and nature often involves a combination of the employee's first initial and last name.
[first_initial][last]@a2apharma.com
Format
skumar@a2apharma.com
Example
75%
Success rate
News and media
BioSpace • November 1, 2023
A2A Pharmaceuticals Announces Oversubscribed $7.2 Million Series A1 Financing
A2A Pharmaceuticals secured $7.2 million in an oversubscribed Series A1 financing round. The funding, co-led by existing investors like New York Ventures and Partnership Fund for New York City, with new participants, will advance A2A's AI-driven pipeline of oncology and orphan disease drug candidates, including progressing its lead oncology asset towards IND....more
A2A Pharmaceuticals (Press Release) • October 19, 2023
A2A Pharmaceuticals to Present at BioFuture 2023 Conference
A2A Pharmaceuticals announced its participation and presentation at the BioFuture 2023 conference, where it showcased its AI-driven drug discovery platform SCULPT™ and its pipeline of novel therapeutics in development for oncology and other critical diseases....more
Business Wire • March 21, 2023
A2A Pharmaceuticals to Present Data on Novel Oncology Drug Candidate at the American Association for Cancer Research (AACR) Annual Meeting 2023
A2A Pharmaceuticals announced it would present preclinical data on one of its leading oncology drug candidates, A2A-161, at the AACR Annual Meeting 2023. The presentation highlighted the compound's mechanism of action and potential in treating specific cancers, discovered using their SCULPT™ AI platform....more
Highperformr’s free tools for company research
Explore Employees by Region or Country
See where a company’s workforce is located, by country or region.
View Funding Details
View past and recent funding rounds with amounts and investors.
Understand Revenue Insights
Understand company revenue estimates and financial scale.
Track Active Job Openings
Track active roles and hiring trends to spot growth signals.
Review Product and Offerings
Discover what a company offers—products, platforms, and solutions.
Get SIC or NAICS Codes
Get the company’s official SIC and NAICS classifications.
Analyze Website Traffic Trends
Analyze visitor volume, engagement, and top traffic sources.
Discover Social Profiles and Engagement
Explore LinkedIn, Twitter, and other active social profiles.
Identify Top Competitors
Identify top competitors based on similar business traits.
Research and Discover Companies with Highperformr — Smarter, Faster
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
- Track intent signals to find buyers who are actively in-market
- Enrich contacts and companies instantly, no need to switch tools
- Automate workflows to stay ahead of every change
- Connect your CRM & tools for seamless data sync and activation
Thousands of companies, including A2A Pharmaceuticals, are just a search away.